Bookmarks
IoN Trial
Population Size
Not reported
Years
2012
Associated BioSamples
Availability to be confirmed
Geographic coverage
United Kingdom
England
Lead time
Other
Summary
Collection of samples and data across the following diseases: Malignant tumour of thyroid gland (disorder).
Documentation
IoN is a multicentre phase II/III asking is ablative radioiodine necessary for low risk differentiated thyroid cancer patients. 560 patients will be recruited and randomised 1:1 to receive radioiodine ablation or no ablation. Samples collected during trial: Stimulated Tg blood samples for patients taken at the treatment visit, 2 months post treatment, 6-9 months post treatment and every 6 months thereafter for 5 years.
Dataset type
Health and disease
Dataset sub-type
Not applicable
Keywords
Trial, Malignant tumour of thyroid gland (disorder), IoN, UKCRC Tissue Directory
Provenance
Image contrast
Not stated
Biological sample availability
Availability to be confirmed
Details
Publishing frequency
Other
Version
1.0.0
Modified
08/10/2024
Citation Requirements
In Progress
Coverage
Start date
01/01/2012
Time lag
Variable
Geographic coverage
United Kingdom, England
Accessibility
Language
en
Controlled vocabulary
LOCAL
Format
In Progress
Data Access Request
Dataset pipeline status
Not available
Access rights
Please contact the publisher using Contact Point details provided.
Time to dataset access
Other
Access request cost
Not specified
Access method category
Varies based on project
Data Controller
University College London